TrialInvestigational new drugs2012

Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia.

H M Kantarjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.